Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC007579
Host Cell : HEK293 (CHO and other cell types are also available) Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC007579 |
| Description | Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level. |
| Target Gene | IL23A |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 (CHO and other cell types are also available) |
| Host Cell Species | Species varies |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | 2 × 10^6 cells / vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry Ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | IL23A interleukin 23, alpha subunit p19 [ Homo sapiens ] |
| Gene Symbol | IL23A |
| Synonyms | P19; SGRF; IL-23; IL-23A; IL23P19 |
| Gene Description | interleukin 23, alpha subunit p19 |
| GeneID | 51561 |
| Uni ProtID | Q9NPF7 |
| mRNA Refseq | NM_016584.2 |
| Protein Refseq | NP_057668.1 |
| Chromosome Location | 12q13.3 |
| Function | cytokine activity; contributes_to interleukin-23 receptor binding; |
| Pathway | ATF-2 transcription factor network, organism-specific biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; IL23-mediated signaling events, organism-specific biosystem; Jak-STAT signaling pathway, organism-specific biosystem; Jak-STAT signaling pathway, conserved biosystem; Pertussis, organism-specific biosystem; |
| MIM | 605580 |
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with metastasis and recurrence posing significant clinical challenges. Although the pro-inflammatory cytokine interleukin-23 (IL-23) has been linked to tumor progression, its cell-autonomous functions within HCC tumor cells remain unclear. Here, researchers found that IL-23 is significantly upregulated in HCC tumor tissues, with even higher expression levels observed in metastatic lesions. Knockdown of the IL-23 receptor (IL-23R) inhibited HCC cell proliferation, colony formation, and migration, whereas overexpression of endogenous IL-23 enhanced these phenotypes. Transcriptomic analysis revealed the enrichment of multiple oncogenic signaling pathways, including TGF-β, JAK/STAT, Hippo, MAPK, and PI3K/AKT/mTOR. Mechanistic studies demonstrated that IL-23 overexpression upregulated the expression of EGFR, AKT, and p-AKT, thereby establishing a novel IL-23/EGFR/AKT signaling axis that drives malignant phenotypes. These findings indicate that autocrine IL-23 promotes HCC progression by enhancing cell proliferation and metastatic potential through the activation of various oncogenic pathways, particularly the autocrine IL-23/EGFR/AKT axis.
In this study, the researchers generated IL-23-overexpressing HCCLM3 and Huh7 cell lines. qRT-PCR and Western blot analyses confirmed that the mRNA and protein levels of IL-23p19 and IL-23p40 were significantly elevated in IL-23-overexpressing HCCLM3 and Huh7 cells compared to their respective controls (Figure 1A–C). Furthermore, ELISA was used to measure IL-23 concentrations in the culture supernatants of the HCC cells. The results demonstrated a significant increase in IL-23 secretion by the IL-23-overexpressing cells, validating the efficacy of the strategy to enhance IL-23 production in HCC cells (Figure 1D). Over a 72-hour observation period, the IL-23-overexpressing cells exhibited significantly accelerated proliferation rates compared to their respective control cells (Figure 1E). Representative images and quantitative analysis from wound-healing assays revealed that high IL-23 expression significantly enhanced cell migration (Figure 1F and G). Colony formation assays showed that the number of colonies formed by IL-23-overexpressing cells was significantly higher than that of the respective control groups (Figure 1H and I). These results indicate that high endogenous IL-23 expression promotes cell proliferation, colony formation, and motility via autocrine signaling pathways, thereby enhancing the malignant phenotype of HCC cells.
Figure 1. Endogenous IL-23 overexpression enhances HCC cell proliferation and migration. (Zhou X, et al., 2026)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.